139 related articles for article (PubMed ID: 8740978)
1. In vivo, synergestic inhibition of MAT-LyLu rat prostatic adenocarcinoma growth by polyamine deprivation and low-dose cyclophosphamide.
Cipolla B; Blanchard Y; Chamaillard L; Quemener V; Guillé F; Havouis R; Moulinoux JP
Urol Res; 1996; 24(2):93-8; discussion 99. PubMed ID: 8740978
[TBL] [Abstract][Full Text] [Related]
2. The growth of MAT-LyLu rat prostatic adenocarcinoma can be prevented in vivo by polyamine deprivation.
Moulinoux JP; Quemener V; Cipolla B; Guillé F; Havouis R; Martin C; Lobel B; Seiler N
J Urol; 1991 Nov; 146(5):1408-12. PubMed ID: 1942311
[TBL] [Abstract][Full Text] [Related]
3. [The involvement of polyamines in the malignant proliferative process. The anticancer effect of polyamine deprivation].
Quemener V; Chamaillard L; Brachet P; Havouis R; Moulinoux JP
Ann Gastroenterol Hepatol (Paris); 1995; 31(3):181-8; discussion 188-9. PubMed ID: 7653990
[TBL] [Abstract][Full Text] [Related]
4. Polyamine deprivation enhances antitumoral efficacy of chemotherapy.
Quemener V; Moulinoux JP; Havouis R; Seiler N
Anticancer Res; 1992; 12(5):1447-53. PubMed ID: 1444206
[TBL] [Abstract][Full Text] [Related]
5. Polyamine deprivation: a new tool in cancer treatment.
Quemener V; Blanchard Y; Chamaillard L; Havouis R; Cipolla B; Moulinoux JP
Anticancer Res; 1994; 14(2A):443-8. PubMed ID: 8017845
[TBL] [Abstract][Full Text] [Related]
6. Polyamine deprivation stimulates natural killer cell activity in cancerous mice.
Chamaillard L; Quemener V; Havouis R; Moulinoux JP
Anticancer Res; 1993; 13(4):1027-33. PubMed ID: 8352521
[TBL] [Abstract][Full Text] [Related]
7. Effect of polyamine deprivation on the survival of intracranial glioblastoma bearing rats.
Sarhan S; Weibel M; Seiler N
Anticancer Res; 1991; 11(2):987-92. PubMed ID: 2064355
[TBL] [Abstract][Full Text] [Related]
8. Effect of early and delayed difluoromethylornithine pretreatment upon cyclophosphamide chemotherapy.
Johnson M; Shaw M; Rubenstein M; Guinan P
Clin Physiol Biochem; 1990; 8(1):11-5. PubMed ID: 2108838
[TBL] [Abstract][Full Text] [Related]
9. Polyamine deprivation prevents the development of tumour-induced immune suppression.
Chamaillard L; Catros-Quemener V; Delcros JG; Bansard JY; Havouis R; Desury D; Commeurec A; Genetet N; Moulinoux JP
Br J Cancer; 1997; 76(3):365-70. PubMed ID: 9252204
[TBL] [Abstract][Full Text] [Related]
10. Endogenous and exogenous polyamines in support of tumor growth.
Seiler N; Sarhan S; Grauffel C; Jones R; Knödgen B; Moulinoux JP
Cancer Res; 1990 Aug; 50(16):5077-83. PubMed ID: 2116224
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of polyamine oxidase improves the antitumoral effect of ornithine decarboxylase inhibitors.
Claverie N; Wagner J; Knodgen B; Seiler N
Anticancer Res; 1987; 7(4B):765-72. PubMed ID: 3118759
[TBL] [Abstract][Full Text] [Related]
12. Benefits of complete polyamine deprivation in hormone responsive and hormone resistant MCF-7 human breast adenocarcinoma in vivo.
Leveque J; Foucher F; Havouis R; Desury D; Grall JY; Moulinoux JP
Anticancer Res; 2000; 20(1A):97-101. PubMed ID: 10769640
[TBL] [Abstract][Full Text] [Related]
13. Effect of polyamine oxidase inhibition on the colonic malignant transformation process induced by 1,2-dimethylhydrazine.
Halline AG; Dudeja PK; Jacoby RF; Llor X; Teng BB; Chowdhury LN; Davidson NO; Brasitus TA
Carcinogenesis; 1990 Dec; 11(12):2127-32. PubMed ID: 2265465
[TBL] [Abstract][Full Text] [Related]
14. Combination therapy using polyamine synthesis inhibitor alpha-difluoromethylornithine and adriamycin in treatment of rats carrying the Dunning R3327 MAT-LyLu prostatic adenocarcinoma.
Shaw MW; Guinan PD; McKiel CF; Dubin A; Rubenstein M
Prostate; 1987; 11(1):87-93. PubMed ID: 3116512
[TBL] [Abstract][Full Text] [Related]
15. The polyamine oxidase inhibitor MDL-72,527 selectively induces apoptosis of transformed hematopoietic cells through lysosomotropic effects.
Dai H; Kramer DL; Yang C; Murti KG; Porter CW; Cleveland JL
Cancer Res; 1999 Oct; 59(19):4944-54. PubMed ID: 10519408
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of the growth of U-251 human glioblastoma in nude mice by polyamine deprivation.
Moulinoux JP; Darcel F; Quemener V; Havouis R; Seiler N
Anticancer Res; 1991; 11(1):175-9. PubMed ID: 2018351
[TBL] [Abstract][Full Text] [Related]
17. The role of polyamine reutilization in depletion of cellular stores of polyamines in non-proliferating tissues.
Bolkenius FN; Seiler N
Biochim Biophys Acta; 1987 Jan; 923(1):125-35. PubMed ID: 3099850
[TBL] [Abstract][Full Text] [Related]
18. Antitumor activity of a novel synthetic polyamine analogue, N,N'-bis-[3-(ethylamino)-propyl]-1-7-heptane diamine: potentiation by polyamine oxidase inhibitors.
Prakash NJ; Bowlin TL; Edwards ML; Sunkara PS; Sjoerdsma A
Anticancer Res; 1990; 10(5A):1281-7. PubMed ID: 2241104
[TBL] [Abstract][Full Text] [Related]
19. Potentiation of apple procyanidin-triggered apoptosis by the polyamine oxidase inactivator MDL 72527 in human colon cancer-derived metastatic cells.
Gossé F; Roussi S; Guyot S; Schoenfelder A; Mann A; Bergerat JP; Seiler N; Raul F
Int J Oncol; 2006 Aug; 29(2):423-8. PubMed ID: 16820885
[TBL] [Abstract][Full Text] [Related]
20. Combined therapeutic effects of conventional agents and an immunomodulator, PSK, on rat prostatic adenocarcinoma.
Mickey DD; Carvalho L; Foulkes K
J Urol; 1989 Dec; 142(6):1594-8. PubMed ID: 2585643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
